Anti-Cancer Drugs

Wolters Kluwer Health Logo

Login
Register
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	Current Issue	Previous Issues	Published Ahead-of-Print	For Authors	Journal Info

About the Journal

Editorial Board

Advertising

Subscription Services

Reprints

Job Opportunities

Rights and Permissions

Mobile

Editor-in-Chief:	Mels Sluyser, PhD
ISSN:	0959-4973
Online ISSN:	1473-5741
Frequency:	10 / year
Ranking:	82 of 141 Oncology, 102 of 216 Pharmacology & Pharmacy
Impact Factor:	2.358

Current Issue: March 2010 - Volume 21 - Issue 3

Subscribe to eTocs

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at Anti-Cancer Drugs.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Current Issue Highlights

Select All | Hide Details

Review Articles

Betulinic acid, a natural compound with potent anticancer effects

Mullauer, Franziska B.; Kessler, Jan H.; Medema, Jan Paul

Anti-Cancer Drugs. 21(3):215-227, March 2010.

doi: 10.1097/CAD.0b013e3283357c62

Purchase Access

+ My Favorites

PDF (283 KB)

Show Abstract

Hide Abstract

Abstract:

Preclinical Reports

Safety evaluation and pharmacokinetics of a novel human tumor necrosis factor-alpha exhibited a higher antitumor activity and a lower systemic toxicity

Li, Meng; Qin, Xin; Xue, Xiaochang; Zhang, Cun; Yan, Zhen; Han, Wei; Komarck, Chris; Wang, Thomas D.; Zhang, Yingqi

Anti-Cancer Drugs. 21(3):243-251, March 2010.

doi: 10.1097/CAD.0b013e328333d5ce

Purchase Access

+ My Favorites

PDF (305 KB)

Show Abstract

Hide Abstract

Abstract:

Clinical Reports

Thymidine phosphorylase expression in metastatic sites is predictive for response in patients with colorectal cancer treated with continuous oral capecitabine and biweekly oxaliplatin

Petrioli, Roberto; Bargagli, Gianluca; Lazzi, Stefano; Pascucci, Alessandra; Francini, Edoardo; Bellan, Cristiana; Conca, Raffaele; Martellucci, Ignazio; Fiaschi, Anna Ida; Lorenzi, Bruno; Francini, Guido; the Multidisciplinary Oncology Group in Gastrointestinal Tumors

Anti-Cancer Drugs. 21(3):313-319, March 2010.

doi: 10.1097/CAD.0b013e328334d88a

Purchase Access

+ My Favorites

PDF (222 KB)

Show Abstract

Hide Abstract

Abstract:

Case Report

Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?

Syrigou, Ekaterini; Makrilia, Nektaria; Vassias, Antonios; Nikolaidis, Ilias; Xyla, Vassilia; Manolopoulos, Leonidas; Syrigos, Kostas

Anti-Cancer Drugs. 21(3):333-338, March 2010.

doi: 10.1097/CAD.0b013e32833418c0

Purchase Access

+ My Favorites

PDF (128 KB)

Show Abstract

Hide Abstract

Abstract:

Table of Contents Sections

Review Articles
Preclinical Reports
Clinical Reports
Case Report

Select All

NEW! Mobile View

Username or Email:

Password:

Remember username
or email

Keep me logged in

Forgot Password?

Need to Activate a New Subscription?
Recently purchased a subscription? Login or Register a new account and enter your subscription ID, or Subscribe Now!

Forgot your Password?

Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.

Email:

Reset Password Link Sent

Link to reset your password has been sent to specified email address.

Keep me logged in

What does "Keep me logged in" mean?
By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your other content, even if you close your browser or shut down your computer.

To protect your most sensitive data and activities (like changing your password), we'll ask you to re-enter your password when you access these services.

What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend that you uncheck the "Keep me logged in" box.